Canada-based pharmacy service to provide Indian-manufactured Ozempic to American consumers

On Wednesday, the online pharmacy service SaveRxCanada.to announced that it is now providing Novo Nordisk's popular diabetes medication, Ozempic, obtained from India, to patients in the United States, amid increasing interest in more affordable alternatives.

The company based in Canada explained that the Ozempic injections sourced from India are available starting at approximately $280 per pen, in contrast to typical US retail prices that usually fall between $900 and $1,100 per pen, varying by dosage and location.

A representative from Novo Nordisk stated that the company will look into the situation, whereas the US Food and Drug Administration did not provide an immediate response to inquiries.

SaveRxCanada.to also failed to respond right away to requests for more information about their sourcing methods.

The service offers multiple pre-filled pens with doses of 0.25 mg, 0.5 mg, and 1 mg, and emphasizes that products clearly indicate the manufacturer and country of origin.

Every purchase demands a legitimate prescription and comes with complimentary shipping, as noted.

"Numerous patients are diligently comparing prescription expenses as US costs keep escalating," the company mentioned in their press release.

Describing itself as a global prescription referral platform, it stated that it has been in operation for 24 years, linking individuals with licensed pharmacies beyond the United States.

Services from international pharmacies have attracted attention from US consumers grappling with increasing personal drug costs.